IXHL · Incannex Healthcare Inc.
$3.21
+0.04 (+1.26%)
At close · Jul 20
Market Cap
$38.41M
Shares
11.96M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.21
Open$3.16
Day$3.05–3.21
52W$2.49–49.80
Avg vol 30d300K
Short int509K · 4.3% float · 1.9d
Short vol31%
DataMar 2022–Jul 2026
Filing10-Q · May 15
Up next
FQ1-27 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.66
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−56%
below
Price vs 50-day avg
−10%
below
RSI (14)
42
neutral
MACD trend
Negative
52-week position
2%
near low
Momentum
relative strength
1-month return
−10%
trailing
6-month return
−68%
trailing
YTD return
−70%
this year
Relative strength
−75%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $7 — 200d above 50d
Institutional flow
Accumulating
+20 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
4.25% of float · ▼ -33.8% MoM · 1.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
20 holders — 13F breadth
Squeeze score
52
elevated · 0–100
Fundamentals
EPS growth
−17%
Y/Y
Free cash flow
$-12.5M
Balance sheet
$15.0M
net cash
Quant / Vol
risk profile
Volatility
161%
annualized · 1-yr
Max drawdown
−95%
past year
ATR
8.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−56%
Bearish
Price vs 50-day avg
−10%
Bearish
RSI (14)
42
Neutral
MACD trend
Negative
Bearish
52-week position
2%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $4 › 200d $7 — 200d above 50d
Institutional flow
Accumulating
+20 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
4.25% of float · ▼ -33.8% MoM · 1.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
20 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $2
Now $3 · 2%
52-wk high $50
vs 200-day avg -56%
vs 50-day avg -10%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IXHL
this stock
Incannex Healthcare Inc.
|
$38.41M | -70.1% | +616.7% | — | 4.3% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$54.78B | +9.4% | — | — | 0.2% |
|
GALDY
Galderma Group AG/ADR
|
$49.74B | +2.3% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$43.71B | -0.7% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IXHL | -3.0% | -9.8% | -67.8% | -14.6% | -70.1% |
| SPY | -1.0% | -0.6% | +7.1% | -0.6% | +8.8% |
| vs SPY | -2.1% | -9.2% | -74.9% | -14.0% | -78.9% |